Marketing-authorisation holder · Canada
Centre for Probe Development and Commercialization
6 medicines in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
6 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| OSTEOVISION11.1 gbq / ml · Solution | Fluoride f-18 | Canada | Not marketed | 2019 |
| PROSTALUMIN3.7 gbq / ml · Solution | Psma-1007 (18 f) | Canada | Authorised | |
| GLUCOVISION (CITRATE)453 gbq / syr · Solution | Fludeoxyglucose [18 f] | Canada | Cancelled | 2018 |
| GLUCOVISION (CITRATE)453 gbq / vial · Solution | Fludeoxyglucose [18 f] | Canada | Cancelled | 2018 |
| GLUCOVISION (PHOSPHATE)540 gbq / vial · Solution | Fludeoxyglucose [18 f] | Canada | Cancelled | 2010 |
| GLUCOVISION (PHOSPHATE)540 gbq / syr · Solution | Fludeoxyglucose [18 f] | Canada | Cancelled | 2013 |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines |
|---|